Complete Mounjaro vs Wegovy Dosage Analysis With UK Pricing
Mounjaro vs Wegovy Dosage: Understanding the Key Differences
When comparing Mounjaro vs Wegovy dosage schedules, the fundamental difference lies in their mechanisms and escalation patterns. Mounjaro utilises tirzepatide, a dual GIP and GLP-1 receptor agonist, starting at 2.5mg weekly and escalating through 5mg, 7.5mg, 10mg, 12.5mg, to a maximum 15mg maintenance dose. Wegovy employs semaglutide, a GLP-1-only approach, beginning at 0.25mg and gradually increasing to 2.4mg over 16 weeks. The Mounjaro escalation typically spans 20 weeks to reach maximum dose, whilst Wegovy achieves maintenance dosing by week 17. Both medications require this careful dose titration to minimise gastrointestinal side effects whilst optimising efficacy.
The storage requirements also differ significantly when evaluating Mounjaro vs Wegovy dosage considerations. Wegovy maintains stability for up to 6 weeks at room temperature once removed from refrigeration, compared to Mounjaro's 21-day limit. This practical advantage makes Wegovy more suitable for frequent travellers or those with inconsistent refrigeration access. Additionally, Wegovy's FlexTouch pen system offers ergonomic injection with clear dose visibility, whilst both medications maintain similar weekly injection schedules throughout their respective escalation phases.
UK Pricing Breakdown: Mounjaro vs Wegovy Dosage Costs
EverydayMeds offers the UK's most competitive Wegovy pricing structure, with single pens starting from £79.99 for the 0.25mg starter dose after applying discount code FIRST40 at checkout. The complete Wegovy escalation costs £624.96 for individual pens (0.25mg £79.99, 0.5mg £94.99, 1mg £99.99, 1.7mg £139.99, 2.4mg £209.99), whilst bundle options provide convenience advantages. Our Intro Trio bundle covers the first 12 weeks for £299.99, representing streamlined ordering without repeated clinical assessments. Returning customers utilise code DOSE25 for continued savings across all dosage strengths.
When examining Mounjaro vs Wegovy dosage economics, the extended escalation period for Mounjaro typically results in higher cumulative costs reaching maximum dose. Wegovy's shorter 16-week escalation to 2.4mg maintenance provides cost predictability, with our Ultimate Stability Trio offering three months of 2.4mg maintenance supply for £649.99. All EverydayMeds pricing includes clinical assessment, prescriber review, and next-day cold-chain delivery, ensuring no hidden fees impact your budget planning. Our GPhC registration #9012878 ensures authentic medication sourcing directly from licensed wholesalers.
Clinical Evidence: Mounjaro vs Wegovy Dosage Efficacy
The STEP clinical trials demonstrated Wegovy's efficacy across its dosage escalation, with STEP 1 showing approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, when used alongside reduced-calorie diet and increased physical activity. Patients typically begin experiencing appetite reduction during the initial 0.25mg and 0.5mg phases, with optimal effects generally achieved at the 2.4mg maintenance dose. The STEP 2 trial specifically examined patients with type 2 diabetes, achieving approximately clinically studied weight loss with the full Wegovy dosage protocol (Wilding et al., NEJM, 2021).
Mounjaro's SURMOUNT trials evaluated the dual GIP/GLP-1 approach across its escalation schedule, though direct comparison between Mounjaro vs Wegovy dosage outcomes requires caution due to different trial populations and methodologies. Both medications demonstrated dose-dependent effects, with higher doses generally correlating with greater efficacy. The key consideration involves individual tolerance during escalation phases, as some patients may require extended periods at intermediate doses before progressing to maintenance levels.
How Wegovy Works Throughout Dosage Escalation
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates blood glucose and gastric emptying. The gradual Mounjaro vs Wegovy dosage escalation allows your body to adapt to enhanced GLP-1 signalling, which reduces appetite by acting on brain appetite centres in the hypothalamus. During the initial 0.25mg phase, patients often notice decreased food cravings and earlier satiety signals, effects that intensify through the 0.5mg and 1mg phases. The 1.7mg dose typically represents the threshold where most patients experience optimal appetite suppression, whilst the 2.4mg maintenance dose sustains long-term weight management benefits. This mechanism differs from Mounjaro's dual-hormone approach but achieves comparable appetite regulation through its targeted GLP-1 pathway.
EverydayMeds Ordering Process for Optimal Dosage Management
Accessing your chosen medication through EverydayMeds begins with our 3-minute online clinical assessment, designed to evaluate your suitability for either option in the Mounjaro vs Wegovy dosage comparison. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring appropriate dose selection and identifying any contraindications. Once approved, your medication ships via next-day cold-chain delivery, maintaining the strict 2-8°C temperature requirements essential for medication integrity. Our system automatically tracks your escalation schedule, sending reminders when transitioning between dosage phases and offering convenient reordering options. This streamlined approach eliminates the complexity often associated with managing prescription weight management medications, whilst maintaining full clinical oversight throughout your treatment journey.
Storage and Practical Considerations for Dosage Management
Proper storage significantly impacts the Mounjaro vs Wegovy dosage effectiveness, with both requiring refrigeration between 2-8°C before first use. Wegovy's superior room temperature stability (6 weeks vs Mounjaro's 21 days) provides practical advantages for dose timing flexibility and travel convenience. The FlexTouch pen system delivers precise dosing with clear graduation marks, ensuring accurate administration throughout the escalation schedule. Each pen contains four weekly doses, meaning the 0.25mg pen provides your first month's treatment, whilst higher-dose pens maintain the same four-week supply. This consistent pen format simplifies dosage transitions, as injection technique and pen handling remain identical across all dose strengths, reducing learning curve complexity during escalation phases.
Why UK Customers Choose EverydayMeds for Mounjaro vs Wegovy Dosage Decisions
EverydayMeds uniquely positions itself in the UK market by offering transparent pricing across the complete Mounjaro vs Wegovy dosage spectrum, eliminating the pricing opacity common with other providers. Our clinical team provides personalised guidance on dosage selection, considering your medical history, lifestyle factors, and treatment goals to recommend the most suitable option. Unlike traditional pharmacy chains, our specialised focus on weight management medications ensures deep expertise in both dosing protocols and practical patient support throughout escalation phases.
Our bundle pricing structure specifically addresses the Mounjaro vs Wegovy dosage economics, offering Getting Started bundles that cover initial escalation phases without requiring separate orders for each dose increase. This approach reduces administrative burden whilst ensuring treatment continuity, particularly important during the critical early weeks when dosage timing consistency impacts side effect management. Additionally, our clinical team remains available throughout your treatment journey, providing guidance on dose progression timing and addressing any concerns that arise during escalation phases, something rarely offered by standard pharmacy services.
Secure Your Lowest UK Pricing on Wegovy Today
Take advantage of the UK's most competitive Wegovy pricing by starting your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy, where new customers apply code FIRST40 and returning customers use DOSE25 at checkout for our published pricing. Our GPhC-registered pharmacy #9012878 ensures you receive authentic Novo Nordisk Wegovy with full cold-chain integrity, whilst our clinical team guides you through the optimal dosage progression for your individual circumstances. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which dosing approach aligns best with your weight management goals. Don't let pricing uncertainty delay your treatment decision – our transparent fee structure includes clinical assessment, prescriber review, and nationwide delivery with no hidden costs. Start your assessment today and join thousands of UK customers who've chosen EverydayMeds for their prescription weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
